Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 12 Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 9 Carcinoma, Non-Small-Cell Lung 2 Thyroid Neoplasms 1 Skin Neoplasms 1 Sexual Dysfunction, Physiological 1 Recurrence 1 Eunuchism 1 Erectile Dysfunction 1

Interventions

Thyroidectomy 5 Iodine-131 5 Surgical Procedures, Operative 3 selpercatinib 2 lenvatinib 2 anlotinib 2 Ultrasonography 2 Transurethral Resection of Prostate 2 Sorafenib 2 Molecular Diagnostic Techniques 2 Interviews as Topic 2 Focus Groups 2 Biopsy, Fine-Needle 2 trastuzumab deruxtecan 1 trametinib 1 pralsetinib 1 pembrolizumab 1 gallium Ga 68 dotatate 1 dabrafenib 1 Triiodothyronine 1 Thyroxine 1 Thyrotropin Alfa 1 Surveys and Questionnaires 1 Routinely Collected Health Data 1 Radiotherapy, Adjuvant 1 Quality of Life 1 Patient Reported Outcome Measures 1 Observation 1 Nivolumab 1 Minimally Invasive Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Thyroid Neoplasms × trametinib × Clear all

NCT07419932 2026-02-19

NeoLATC

Fujian Medical University

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡